YEARS

2007-2008

AUTHORS

Steven C Ghivizzani

TITLE

5th international meeting of gene and cell therapies for arthritis and related di

ABSTRACT

Principal Investigator/Program Director (Last, first, middle): Ghivizzani, Steven, C RESEARCH & RELATED Other Project Information 1. * Are Human Subjects Involved? m Yes l No 1.a. If YES to Human Subjects Is the IRB review Pending? m Yes m No IRB Approval Date: Exemption Number: 1 2 3 4 5 6 Human Subject Assurance Number 2. * Are Vertebrate Animals Used? m Yes l No 2.a. If YES to Vertebrate Animals Is the IACUC review Pending? m Yes m No IACUC Approval Date: Animal Welfare Assurance Number 3. * Is proprietary/privileged information m Yes l No included in the application? 4.a.* Does this project have an actual or potential impact on m Yes l No the environment? 4.b. If yes, please explain: 4.c. If this project has an actual or potential impact on the environment, has an exemption been authorized or an environmental assessment (EA) or environmental impact statement (EIS) been performed? m Yes m No 4.d. If yes, please explain: 5.a.* Does this project involve activities outside the U.S. or m Yes l No partnership with International Collaborators? 5.b. If yes, identify countries: 5.c. Optional Explanation: 6. * Project Summary/Abstract 764-GTARD_abstract.pdf Mime Type: application/pdf 7. * Project Narrative 2773-narrative.pdf Mime Type: application/pdf 8. Bibliography & References Cited 9. Facilities & Other Resources 10. Equipment Tracking Number: Other Information Page 5 OMB Number: 4040-0001 Expiration Date: 04/30/2008 Principal Investigator/Program Director (Last, first, middle): Ghivizzani, Steven, C This proposal requests partial support for the 5th International Meeting on Gene and Cell Therapies for Arthritis and Related Disorders to be held in Seattle Washington, at the Bell Harbor Conference Center April 29-May 1, 2008. The purpose of the meeting is to increase our understanding of rheumatologic and orthopaedic disorders, and the application of genetic, biologic and cell-based technologies for their treatment. The long- term goals of this continuing series of meetings are to accelerate pre-clinical research and development of these treatment approaches, and facilitate their translation into clinical application. The specific aims of the current meeting will be to convene 31 speakers that represent critical aspects of the relevant scientific areas with a total of up to 100 participants for a three day conference to review and discuss scientific progress, establish collaborative relationships and chart future research directions. The meeting program will feature a keynote address and eight sessions that broadly address Developments in Gene Transfer Technologies, Gene and Biological Approaches for Arthritis, Innovative Approaches to Immunomodulation, Strategies for Bone and Cartilage Healing, Regulatory Issues and Clinical Studies for Arthritis, and Bone and Cartilage Repair. There will also be a poster session as well as a dedicated oral session for Young Investigators, enabling all attendees the opportunity to actively participate in the conference. Project Description Page 6

FUNDED PUBLICATIONS

  • Gene therapy of the rheumatic diseases: 1998 to 2008.
  • Orthopedic gene therapy in 2008.
  • Gene therapy of the rheumatic diseases: 1998 to 2008
  • How to use: Click on a object to move its position. Double click to open its homepage. Right click to preview its contents.

    Download the RDF metadata as:   json-ld nt turtle xml License info


    20 TRIPLES      17 PREDICATES      21 URIs      9 LITERALS

    Subject Predicate Object
    1 grants:eee9d62a6e5a2642543c74a9d5043d1e sg:abstract Principal Investigator/Program Director (Last, first, middle): Ghivizzani, Steven, C RESEARCH & RELATED Other Project Information 1. * Are Human Subjects Involved? m Yes l No 1.a. If YES to Human Subjects Is the IRB review Pending? m Yes m No IRB Approval Date: Exemption Number: 1 2 3 4 5 6 Human Subject Assurance Number 2. * Are Vertebrate Animals Used? m Yes l No 2.a. If YES to Vertebrate Animals Is the IACUC review Pending? m Yes m No IACUC Approval Date: Animal Welfare Assurance Number 3. * Is proprietary/privileged information m Yes l No included in the application? 4.a.* Does this project have an actual or potential impact on m Yes l No the environment? 4.b. If yes, please explain: 4.c. If this project has an actual or potential impact on the environment, has an exemption been authorized or an environmental assessment (EA) or environmental impact statement (EIS) been performed? m Yes m No 4.d. If yes, please explain: 5.a.* Does this project involve activities outside the U.S. or m Yes l No partnership with International Collaborators? 5.b. If yes, identify countries: 5.c. Optional Explanation: 6. * Project Summary/Abstract 764-GTARD_abstract.pdf Mime Type: application/pdf 7. * Project Narrative 2773-narrative.pdf Mime Type: application/pdf 8. Bibliography & References Cited 9. Facilities & Other Resources 10. Equipment Tracking Number: Other Information Page 5 OMB Number: 4040-0001 Expiration Date: 04/30/2008 Principal Investigator/Program Director (Last, first, middle): Ghivizzani, Steven, C This proposal requests partial support for the 5th International Meeting on Gene and Cell Therapies for Arthritis and Related Disorders to be held in Seattle Washington, at the Bell Harbor Conference Center April 29-May 1, 2008. The purpose of the meeting is to increase our understanding of rheumatologic and orthopaedic disorders, and the application of genetic, biologic and cell-based technologies for their treatment. The long- term goals of this continuing series of meetings are to accelerate pre-clinical research and development of these treatment approaches, and facilitate their translation into clinical application. The specific aims of the current meeting will be to convene 31 speakers that represent critical aspects of the relevant scientific areas with a total of up to 100 participants for a three day conference to review and discuss scientific progress, establish collaborative relationships and chart future research directions. The meeting program will feature a keynote address and eight sessions that broadly address Developments in Gene Transfer Technologies, Gene and Biological Approaches for Arthritis, Innovative Approaches to Immunomodulation, Strategies for Bone and Cartilage Healing, Regulatory Issues and Clinical Studies for Arthritis, and Bone and Cartilage Repair. There will also be a poster session as well as a dedicated oral session for Young Investigators, enabling all attendees the opportunity to actively participate in the conference. Project Description Page 6
    2 sg:endYear 2008
    3 sg:fundingAmount 30000.0
    4 sg:fundingCurrency USD
    5 sg:hasContribution contributions:37bc55c277fbdb57dbdd1fd5b3b85ff3
    6 sg:hasFieldOfResearchCode anzsrc-for:11
    7 anzsrc-for:1103
    8 sg:hasFundedPublication articles:db6a3d8aee4c28c3f3fb77384a97e48d
    9 articles:e498d41b389c95e65a07e6801127ab9b
    10 articles:f8bab99f1de3834be05fc6ee9144275a
    11 sg:hasFundingOrganization grid-institutes:grid.420086.8
    12 sg:hasRecipientOrganization grid-institutes:grid.15276.37
    13 sg:language English
    14 sg:license http://scigraph.springernature.com/explorer/license/
    15 sg:scigraphId eee9d62a6e5a2642543c74a9d5043d1e
    16 sg:startYear 2007
    17 sg:title 5th international meeting of gene and cell therapies for arthritis and related di
    18 sg:webpage http://projectreporter.nih.gov/project_info_description.cfm?aid=7616969
    19 rdf:type sg:Grant
    20 rdfs:label Grant: 5th international meeting of gene and cell therapies for arthritis and related di
    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular JSON format for linked data.

    curl -H 'Accept: application/ld+json' 'http://scigraph.springernature.com/things/grants/eee9d62a6e5a2642543c74a9d5043d1e'

    N-Triples is a line-based linked data format ideal for batch operations .

    curl -H 'Accept: application/n-triples' 'http://scigraph.springernature.com/things/grants/eee9d62a6e5a2642543c74a9d5043d1e'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'http://scigraph.springernature.com/things/grants/eee9d62a6e5a2642543c74a9d5043d1e'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'http://scigraph.springernature.com/things/grants/eee9d62a6e5a2642543c74a9d5043d1e'






    Preview window. Press ESC to close (or click here)


    ...